Statistics
Publications
6
Citations
324
H-Index
6
Active since
1995
Affiliations
Kelly H. Donaldson is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, molecular pharmacology, and potency optimization.
Publications per year
1995–2010
6
6
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors
Tara Rheault, Thomas R. Caferro, Scott H. Dickerson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 83 citations · Full text
David Uehling, Kelly H. Donaldson, David N. Deaton et al. · Journal of Medicinal Chemistry · 2001 · 62 citations · Full text
Tara Rheault, Kelly H. Donaldson, Jennifer G. Badiang-Alberti et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 16 citations · Full text
1–5 of 6